NCT04870320 - Study of Attention and Memory Treatments for Cancer Survivors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Interventions

BEHAVIORAL

Endeavor: Computer-Based Cognitive Stimulation Intervention

Endeavor application will be utilized by participant on iPad

BEHAVIORAL

Words!: Computer-Based Cognitive Stimulation Intervention

Words! application will be utilized by participant on iPad

OTHER

Quality of Life (QOL) Questionnaires

Standardized QOL questionnaire will be administered at each study visit

Trial Locations (1)

University of California San Francisco, San Francisco

All Listed Sponsors

collaborator

Akili Interactive Labs, Inc.

INDUSTRY

lead

University of California, San Francisco

OTHER